These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18547416)
1. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Staedke SG; Jagannathan P; Yeka A; Bukirwa H; Banek K; Maiteki-Sebuguzi C; Clark TD; Nzarubara B; Njama-Meya D; Mpimbaza A; Rosenthal PJ; Kamya MR; Wabwire-Mangen F; Dorsey G; Talisuna AO Malar J; 2008 Jun; 7():107. PubMed ID: 18547416 [TBL] [Abstract][Full Text] [Related]
2. Pharmacovigilance of antimalarial treatment in Africa: is it possible? Talisuna AO; Staedke SG; D'Alessandro U Malar J; 2006 Jun; 5():50. PubMed ID: 16780575 [TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Maiteki-Sebuguzi C; Jagannathan P; Yau VM; Clark TD; Njama-Meya D; Nzarubara B; Talisuna AO; Kamya MR; Rosenthal PJ; Dorsey G; Staedke SG Malar J; 2008 Jun; 7():106. PubMed ID: 18547415 [TBL] [Abstract][Full Text] [Related]
4. Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries. Kajungu DK; Erhart A; Talisuna AO; Bassat Q; Karema C; Nabasumba C; Nambozi M; Tinto H; Kremsner P; Meremikwu M; D'Alessandro U; Speybroeck N PLoS One; 2014; 9(5):e96388. PubMed ID: 24787710 [TBL] [Abstract][Full Text] [Related]
5. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children. Bélard S; Ramharter M; Kurth F Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099 [TBL] [Abstract][Full Text] [Related]
6. Profile of adverse events in patients receiving treatment for malaria in urban Ghana: a cohort-event monitoring study. Dodoo AN; Fogg C; Nartey ET; Ferreira GL; Adjei GO; Kudzi W; Sulley AM; Kodua A; Ofori-Adjei D Drug Saf; 2014 Jun; 37(6):433-48. PubMed ID: 24788801 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials. Assefa DG; Zeleke ED; Bekele D; Tesfahunei HA; Getachew E; Joseph M; Manyazewal T Malar J; 2021 Apr; 20(1):174. PubMed ID: 33794897 [TBL] [Abstract][Full Text] [Related]
8. Adverse event monitoring of artemesinin combination therapy in Nigeria: the challenges and limitations of the study. Oshikoya KA West Afr J Med; 2010; 29(4):221-4. PubMed ID: 20931507 [TBL] [Abstract][Full Text] [Related]
9. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring. Kuemmerle A; Dodoo AN; Olsson S; Van Erps J; Burri C; Lalvani PS Malar J; 2011 Mar; 10():57. PubMed ID: 21388536 [TBL] [Abstract][Full Text] [Related]
10. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813 [TBL] [Abstract][Full Text] [Related]
11. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa. O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. Tinto H; Sevene E; Dellicour S; Calip GS; d'Alessandro U; Macete E; Nakanabo-Diallo S; Kazienga A; Valea I; Sorgho H; Valá A; Augusto O; Ruperez M; Menendez C; Ouma P; Desai M; Ter Kuile F; Stergachis A Reprod Health; 2015 Dec; 12():112. PubMed ID: 26637464 [TBL] [Abstract][Full Text] [Related]
13. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa. Mehta U; Durrheim D; Mabuza A; Blumberg L; Allen E; Barnes KI Drug Saf; 2007; 30(10):899-910. PubMed ID: 17867727 [TBL] [Abstract][Full Text] [Related]
14. Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial. Byakika-Kibwika P; Achan J; Lamorde M; Karera-Gonahasa C; Kiragga AN; Mayanja-Kizza H; Kiwanuka N; Nsobya S; Talisuna AO; Merry C BMC Infect Dis; 2017 Dec; 17(1):794. PubMed ID: 29281988 [TBL] [Abstract][Full Text] [Related]
15. Caregivers' treatment-seeking behaviors and predictors of whether a child received an appropriate antimalarial treatment: a household survey in rural Uganda. Kassam R; Sekiwunga R; Collins JB; Tembe J; Liow E BMC Infect Dis; 2016 Sep; 16(1):478. PubMed ID: 27600604 [TBL] [Abstract][Full Text] [Related]
16. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. Yeka A; Banek K; Bakyaita N; Staedke SG; Kamya MR; Talisuna A; Kironde F; Nsobya SL; Kilian A; Slater M; Reingold A; Rosenthal PJ; Wabwire-Mangen F; Dorsey G PLoS Med; 2005 Jul; 2(7):e190. PubMed ID: 16033307 [TBL] [Abstract][Full Text] [Related]